Atlas Trials

Safety, Efficacy, and Pharmacodynamics of a 60-Minute Infusion of Carfilzomib for Progressive Multiple Myeloma

Clinical trial NCT01792102 · UNKNOWN

Trial details

NCT number
NCT01792102
Sponsor
Oncotherapeutics
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2013-04-01
Primary completion
2018-12-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.